FORA Capital’s Avidity Biosciences RNAM Stock Holding History

FORA Capital’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,997	Closed	-$1.37M	–	576
2025 Q4	$1.37M	Buy	+18,997	New	+$1.23M	0.17%	164
2025 Q1	–	Sell	-18,787	Closed	-$546K	–	634
2024 Q4	$546K	Buy	+18,787	New	+$785K	0.06%	254

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

FORA Capital's RNAM Position: Q1 2026 in Review

FORA Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 18,997 shares — an estimated $1.37M sold.

FORA Capital first reported a position in RNAM in Q4 2024 and held it in 2 quarters. The position peaked at $1.37M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

FORA Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
FORA Capital sold 18,997 Avidity Biosciences shares in Q1 2026, an estimated $1.37M.
FORA Capital first reported a position in Avidity Biosciences in Q4 2024 and held it in 2 quarters.
FORA Capital's Avidity Biosciences position peaked at $1.37M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.